Medicare Enrolled
Dr. Laurie Welton, DO
Infectious Disease · Sebastian, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Welton from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Welton?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Welton
Dr. Laurie Welton is an infectious disease specialist in Sebastian, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Welton performed 625,042 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Welton received a total of $7,494 from 33 pharmaceutical and/or device companies across 260 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Welton is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 1% volume in FL
$7,494 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗625,042
Medicare services
Top 1% in FL for infectious disease
Not available
Unique patients (not deduplicated)
$1
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Daptomycin antibiotic injection | 590,201 | $0 | $1 |
| Vedolizumab infusion (Entyvio) This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams. |
17,110 | $17 | $27 |
| Denosumab injection (Prolia/Xgeva) | 6,121 | $18 | $28 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
5,958 | $26 | $110 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
1,302 | $51 | $150 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
808 | $0 | $4 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
724 | $69 | $127 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
713 | $100 | $191 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
299 | $8 | $25 |
| Ertapenem sodium injection, 500 mg An injection of ertapenem sodium, an antibiotic medication, administered at a dose of 500 mg. |
287 | $11 | $80 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
216 | $98 | $249 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
207 | $97 | $165 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
184 | $10 | $45 |
| Vancomycin injection, 500 mg A 500 mg dose of vancomycin antibiotic is administered via injection. |
159 | $2 | $8 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
135 | $15 | $45 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
124 | $131 | $300 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
109 | $23 | $60 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
87 | $30 | $74 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
67 | $16 | $50 |
| Injection, tobramycin sulfate, up to 80 mg | 67 | $2 | $8 |
| Vein wound compression bandage application, lower leg, ankle, and foot Application of compression bandages to the lower leg, ankle, and foot to manage vein-related wounds. |
66 | $76 | $128 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
26 | $89 | $195 |
| New patient office visit, complex (60-74 min) | 22 | $148 | $374 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $142 | $300 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
17 | $42 | $132 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $134 | $260 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
3.9% high complexity
95.7% medium
0.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,494
Total received (2018-2024)
Avg $1,071/year across 7 years
Top 17% in FL for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
260
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$353
2023
$906
2022
$1,010
2021
$304
2020
$741
2019
$3,361
2018
$818
Payments by company (2024)
Merck Sharp & Dohme LLC
$150
Insmed, Inc.
$73
Astellas Pharma US Inc
$25
ViiV Healthcare Company
$24
Gilead Sciences, Inc.
$23
Shionogi Inc
$21
Paratek Pharmaceuticals, Inc.
$19
ABBVIE INC.
$18
Top 3 companies account for 70.0% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan Inc.
$2,694
Janssen Biotech, Inc.
$603
Gilead Sciences, Inc.
$538
Insmed, Inc.
$440
ViiV Healthcare Company
$399
Cumberland Pharmaceuticals, Inc.
$369
Amgen Inc.
$341
Paratek Pharmaceuticals, Inc.
$318
Merck Sharp & Dohme LLC
$259
Merck Sharp & Dohme Corporation
$216
Shionogi Inc
$196
Janssen Products, LP
$191
Theravance Biopharma, Inc.
$158
Daiichi Sankyo Inc.
$141
Janssen Scientific Affairs, LLC
$101
AbbVie Inc.
$70
ABBVIE INC.
$66
Melinta Therapeutics, LLC
$60
Astellas Pharma US Inc
$54
GlaxoSmithKline, LLC.
$48
Horizon Therapeutics plc
$33
Lifenet Health
$24
Nabriva Therapeutics, plc
$23
Genentech USA, Inc.
$22
Ferring Pharmaceuticals Inc.
$17
Takeda Pharmaceuticals U.S.A., Inc.
$17
INSYS Therapeutics Inc
$15
Vyera Pharmaceuticals, LLC
$15
MAYNE PHARMA INC.
$15
EPI Health, LLC
$14
Smith+Nephew, Inc.
$14
PFIZER INC.
$11
Next Science LLC
$11
Top 3 companies account for 51.2% of all-time payments
Associated products mentioned in payments ›
AVYCAZ · Arikayce · Bensal HP · CABENUVA · COLLAGENASE SANTYL · CRESEMBA · Cresemba · DALVANCE · DIFICID · DOVATO · Daraprim Tablet 25mg · EVENITY · Entyvio · Fetroja · GraftLink TS · INFLECTRA · INJECTAFER · ISENTRESS · JULUCA · KRYSTEXXA · Kimyrsa · NOXAFIL · NUZYRA · Orbactiv · PIFELTRO · PREZCOBIX · Prolia · REBYOTA · REMICADE · RUKOBIA · Rituxan · STELARA · SYMTUZA · SYNDROS · SurgX · Symtuza · TEFLARO · VIBATIV · Vemlidy · Vibativ · Xenleta · ZERBAXA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Infectious diseases in nearby ZIP areas
14
County median income
$71,049
Nearest hospital to ZIP centroid (approximate)
ORLANDO HEALTH SEBASTIAN RIVER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Welton is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Welton experienced with daptomycin antibiotic injection?
Based on Medicare claims data, Dr. Welton performed 590,201 daptomycin antibiotic injection services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Welton receive payments from pharmaceutical companies?
Yes. Dr. Welton received a total of $7,494 from 33 companies across 260 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Welton's costs compare to other infectious diseases in Sebastian?
Dr. Welton's average Medicare payment per service is $1. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Welton) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Infectious Diseases in Sebastian
Browse infectious diseases in Sebastian ranked by procedure volume and transparency data.
Highest volume
Top Infectious Diseases in FL
Infectious diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Infectious Diseases in FL
Which FL infectious diseases receive the most from drug and device companies.
By company
Allergan Inc. Payments to Doctors
See all physicians who received payments from Allergan Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology